Updates: MET targeted therapy for EXON 14 mutations in lung cancer
A new editorial paper titled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published in Oncotarget.
Sep 11, 2023
0
13
A new editorial paper titled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published in Oncotarget.
Sep 11, 2023
0
13
A new editorial paper titled "Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis" has been published in Oncotarget.
Sep 6, 2023
0
0
A new research paper titled "Analytic validation of NeXT Dx, a comprehensive genomic profiling assay" has been published in Oncotarget.
Aug 30, 2023
0
8
A new research perspective titled "Adopted neoplastic cells and the consequences of their existence" has been published in Oncotarget.
Aug 29, 2023
0
22
A new editorial paper titled "A macrophage is a macrophage is a macrophage—in metastasis" has been published in Oncotarget.
Aug 23, 2023
0
1
A new editorial paper titled "Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?" has been published in Oncotarget.
Aug 21, 2023
0
0
A new editorial paper was published in Oncotarget, titled "Inhibition of glutamine metabolism: acting on tumoral cells or on tumor microenvironment?"
Aug 16, 2023
0
1
A new review paper was published in Oncotarget entitled, "Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies."
Aug 14, 2023
0
11
A new research perspective titled "CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies" has been published in Oncotarget.
Aug 9, 2023
0
1
A new editorial paper titled "AGO2 in T-prolymphocytic leukemia: its canonical and noncanonical deregulation and function" has been published in Oncotarget.
Aug 7, 2023
0
2